Inferring gene expression from cell-free DNA fragmentation profiles
Mohammad Shahrokh Esfahani(Stanford Medicine), Ash A. Alizadeh(California Institute for Regenerative Medicine), Aaron M. Newman(California Institute for Regenerative Medicine), Joanne Soo(Stanford Medicine), Barzin Y. Nabet(Gene Therapy Laboratory), André Schultz, Everett J. Moding(Stanford Medicine), Matthew J. Frank(Stanford Blood Center), Emily G. Hamilton(Stanford University), Mahya Mehrmohamadi(Cornell University), Bob T. Li(Memorial Sloan Kettering Cancer Center), Michael S. Binkley(Palo Alto University), Monica Nesselbush(Human Genome Sciences (United States)), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Chih Long Liu(Stanford University), Henning Stehr(Stanford University), Charles Macaulay(Stanford Medicine), Daniel A. King(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Chloé B. Steen(Stanford University), Brian J. Sworder(City Of Hope National Medical Center), David M. Kurtz(Stanford University), Stefan Alig(Heidelberg University), Jacob J. Chabon(Foresight Science & Technology (United States)), Joseph G. Schroers‐Martin(Stanford University), James M. Isbell(Memorial Sloan Kettering Cancer Center), Maximilian Diehn(Stanford University), Binbin Chen(Stanford University), Angela BY Hui(Stanford University)
Cited by 213
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k